SGLT2 Inhibitors Must be Discontinued by Patients Before Surgery
WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) recently approved label changes for SGLT2 inhibitors. The FDA said that it recommends doctors advise patients to discontinue SGLT2 medications [...]